Published in Medical Letter on the CDC and FDA, June 15th, 2008
"The availability of FDA-approved continuous-use 90 mu g levonorgestrel/20 mu g ethinyl estradiol will help mainstream continuous oral contraception in the same way that Preven (TM) and Plan B (R)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA